Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Bayesian Methods in Medical Product Development and Comparative Effectiveness

Session Chair(s)

David  Ohlssen, PhD

David Ohlssen, PhD

Senior Expert Methodologist

Novartis Pharmaceuticals Corporation, United States

Hierarchical Bayesian Methods for Combining Efficacy and Safety in Multiple Treatment Comparisons

Learning Objective : Discuss the importance of Bayesian methods in drug development; Examine comparative effectiveness and medical product development case studies; Identify the strategies for education in Bayesian methods.

Speaker(s)

Karen Lynn Price, PhD

An Overview of the Bayesian DIA Working Group

Karen Lynn Price, PhD

Eli Lilly and Company, United States

Senior Research Fellow, Statistical Innovation Center/Design Hub

Bradley P. Carlin, PhD, MS

Hierarchical Bayesian Methods for Combining Efficacy and Safety in Multiple Treatment Comparisons

Bradley P. Carlin, PhD, MS

PharmaLex, United States

Senior Advisor, Data Science and Statistics

Lisa  LaVange, PhD

Panelist

Lisa LaVange, PhD

University of North Carolina at Chapel Hill, United States

Professor Emerita

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.